Vaccine Hesitancy

Vaccines
0
Pipeline Programs
1
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%
+ 2 programs with unclassified modality

Competitive Landscape

1 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
3 programs
LetsTalkShotsN/A1 trial
StorytellingN/A1 trial
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic GroupsN/AVaccine1 trial
Active Trials
NCT06482450RecruitingEst. Jun 2026
NCT06297876Completed100Est. Aug 2024
NCT06639386Recruiting80Est. Mar 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Merck & Co.LetsTalkShots
Merck & Co.Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Merck & Co.Storytelling

Clinical Trials (3)

Total enrollment: 180 patients across 3 trials

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

Start: Jun 2025Est. completion: Jun 2026
N/ARecruiting
NCT06639386Merck & Co.Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

Start: Jan 2025Est. completion: Mar 202680 patients
N/ARecruiting

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

Start: May 2023Est. completion: Aug 2024100 patients
N/ACompleted

Related Jobs in Vaccines

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 180 patients
1 companies competing in this space